|
|
Diagnostic values of interleukin-22 and four items detection of liver fibrosis on liver fibrosis degree |
YANG Jie-wen1 HONG Jun-na2 FANG Jia2 XUE Feng1 JIN Wei-xun1 |
1.Department of Emergency,Tangxia Hospital of Dongguan City in Guangdong Province,Dongguan 523721,China;
2.Department of Medicine,Tangxia Hospital of Dongguan City in Guangdong Province,Dongguan 523721,China |
|
|
Abstract Objective To observe the diagnostic values of interleukin-22 (IL-22)and four items detection of liver fibrosis on the liver fibrosis degree.Methods A tatal of 90 cases of patients diagnosed with liver fibrosis by needle biopsy in Tangxia Hospital of Dongguan City from December 2013 to December 2017 were selected as the subjects.The levels of serum IL-22 and four items of liver fibrosis[hyaluronic acid(HA),collagen typeⅣ (C-Ⅳ),procollagenⅢN-terminal peptide(PⅢNP),laminin(LN)]were compared in patients with liver fibrosis at different pathological stages,and the correlation between the above serological indexes and the liver fibrosis degree and its diagnostic values on the liver fibrosis degree were analyzed.Results The serum levels of IL-22,HA,C-Ⅳ,PⅢNP and LN were increased with the severity of liver fibrosis(P<0.05).Spearman correlation analysis showed that serum levels of IL-22,HA,C-Ⅳ,PⅢNP and LN were significantly and positively correlated with the liver fibrosis degree (r=0.634,0.612,0.563,0.551,0.547,P<0.05).The diagnostic accuracy of liver fibrosis degree was 84.68%by combined diagnosis of serum IL-22,HA,C- Ⅳ,PⅢNP and LN,which was significantly higher than that by single detection with 77.59% (P<0.05).Conclusion The levels of serum IL-22 and four items of liver fibrosis are increased with the severity of liver fibrosis,and there is a significant positive correlation with liver fibrosis degree.The combined detection of above indexes can significantly improve the diagnostic accuracy of liver fibrosis degree.
|
|
|
|
|
[1] |
孙亚朦,贾继东.慢性乙型肝炎抗病毒治疗后肝纤维化逆转的病理定性评估[J].临床肝胆病杂志,2017,33(7):1217.
|
[2] |
高鹏,李俊峰,周伟,等.乙型肝炎病毒对不同ALT状态下慢性乙型肝炎患者肝功和肝纤维化以及肝脏病理分期的影响[J].西安交通大学学报(医学版),2017,38(4):564-568.
|
[3] |
张迪,张雅敏,崔子林,等.白细胞介素-22对肝纤维化小鼠肝部分切除术后肝再生的作用[J].中华肝胆外科杂志,2017,23(1):48-53.
|
[4] |
中华医学会肝病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华内科杂志,2011,50(2):1-12.
|
[5] |
中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华内科杂志,2000,40(6):324-329.
|
[6] |
刘婷,徐铭益.肝纤维化的血清学诊断研究进展[J].实用肝脏病杂志,2016,19(1):125-128.
|
[7] |
陈姝延,孙亚朦,尤红.肝纤维化诊断的新进展[J].中华肝脏病杂志,2017,25(8):563-565.
|
[8] |
贾士杰,谭行华.瞬时弹性成像联合APRI及HA在慢性乙肝患者肝纤维化无创诊断中的应用[J].肝胆外科杂志,2017,25(4):285-288.
|
[9] |
贾军,安公保.HBV 纤维化患者 HA、LN、PⅢP、CⅣ结果分析[J].国际检验医学杂志,2017,38(18):2617-2619.
|
[10] |
李涛,徐宁,吴子安,等.PⅢNP在肝纤维化诊断中的作用[J].国际检验医学杂志,2015,36(9):1306-1307.
|
[11] |
高世乐,胡宗涛,董六一,等.肝纤维化4项在原发性肝癌放疗前后变化的意义[J].医学研究杂志,2017,46(11):153-156.
|
[12] |
吴海沁,赵娟娟,李捍卫,等.肝硬化患者Th1/Th22失衡特点及其与病程进展的关系[J].中华肝脏病杂志,2017,25(10):738-743.
|
[13] |
石城,雷荣娥,胡榜利,等.IL-22 经 Wnt/β-catenin 通路抑制肝星状细胞致纤维化作用[J].中国免疫学杂志,2017,33(4):502-506.
|
[14] |
许春杰,顾磊,蒋春晖,等.1,25(OH)2D3 抑制肝星状细胞激活和调控Th细胞分化治疗肝纤维化[J].实用医学杂志,2017,33(13):2100-2104.
|
[15] |
魏梅娟,张纯瑜,肖子鸿,等.血清“肝纤四项”联合检测诊断模型的建立[J].中国肝脏病杂志(电子版),2015,7(1):86-90.
|
|
|
|